Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia

OBJECTIVE: To evaluate the long-term safety and efficacy of deutetrabenazine in patients with tardive dyskinesia (TD). METHOD: Patients with TD who completed the 12 week, phase 3, placebo-controlled trials were eligible to enter this open-label, single-arm study. The open-label study consisted of a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Neurol Neurosurg Psychiatry
Hlavní autoři: Fernandez, Hubert H, Stamler, David, Davis, Mat D, Factor, Stewart A, Hauser, Robert A, Jimenez-Shahed, Joohi, Ondo, William G, Jarskog, L Fredrik, Woods, Scott W, Bega, Danny, LeDoux, Mark S, Shprecher, David R, Anderson, Karen E
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2019
Témata:
Movement Disorders
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6902058/
https://ncbi.nlm.nih.gov/pubmed/31296586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2018-319918
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky